Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-02-11

Clinical Trial Update: Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing glyburide with insulin for gestational diabetes (White's classification A2) was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glyburide (glyburide)
  • Insulin (insulin)

Snippet

Sponsor: Tripler Army Medical Center | Conditions: Gestational Diabetes | Phase 4 | Status: WITHDRAWN